NORTHAMPTON, MA / ACCESS Newswire / April 4, 2025 / Elanco:
Recently, Elanco marked a significant milestone at its Huningue, France site by breaking ground on a 5,000 sq/m site expansion project. The site specializes in tablet production, so this expansion will help meet increased product demand and support the production of Elanco's latest innovations, helping pets live longer healthier lives.
Elanco is one of only two Animal Health companies that manufactures products in all four Pet Health categories-parasiticides, dermatology, pain, and vaccines. The Huningue, France site manufactures three of these four categories. Over the past several years, the site has been expanding to further enable Elanco's ability to support product innovation for its pet health customers around the world.
This project includes:
750 square meters of new production space
Expanded storage capacity
Additional quality control space
50 new positions, representing a 20% workforce growth at the site.
Celebrating this moment were Jared Inman, Site Director, Paul Riga, DVM, eMBA, President of Elanco France, Grace McArdle, Executive Vice President - Manufacturing, Frederic Rohmer, Vice President Manufacturing small Molecules, as well as elected officials from the Grand Est region and all the 230 employees of the site.
View additional multimedia and more ESG storytelling from Elanco on 3blmedia.com.
Contact Info:
Spokesperson: Elanco
Website: https://www.3blmedia.com/profiles/elanco
Email: info@3blmedia.com
SOURCE: Elanco
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。